| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000036481 |
| Receipt No. | R000041387 |
| Scientific Title | Effects of whole grain soybean beverage on equol production ability, pre- or post-menstrual disorder syndrome symptoms (physiological and mental symptoms) |
| Date of disclosure of the study information | 2019/04/13 |
| Last modified on | 2020/12/19 (Ver. 9) |
| Basic information | ||
| Public title | Effects of whole grain soybean beverage on equol production ability, pre- or post-menstrual disorder syndrome symptoms (physiological and mental symptoms) | |
| Acronym | Whole grain soybean beverage intake trial | |
| Scientific Title | Effects of whole grain soybean beverage on equol production ability, pre- or post-menstrual disorder syndrome symptoms (physiological and mental symptoms) | |
| Scientific Title:Acronym | Whole grain soybean beverage intake trial | |
| Region |
|
|
| Condition | |||
| Condition | Target population is young healthy women with menstrual and premenstrual disorder without g gynecological treatment. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Long-term whole grain soybean beverage (WGS) intake will be performed to soybean products eating habit free population. WGS is expected to improve menstrual and premenstrual disorder through intestinal microbial flora change. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | -The comparison of equol in urine between initial and final samples after 12 weeks intake.
-Improvement of menstrual and premenstrual major disorder during intake. |
| Key secondary outcomes | 1) Time course study of equol content in urine.
2) Questionnaires on menstrual and premenstrual disorder (physical or mental aspects). 3) Relation of Microbialflora in intestine to outcomes. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Whole grain soybean milk, total energy 88 kcal/portion
-12 week intervention -Administration, one portion (125 mL) per day |
|
| Interventions/Control_2 | Milk protein and coco-oil substituted soybean free 'soybean-like' beverage (88 kcal/portion)
-12 week intervention -Administration, one portion (125 mL) per day |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | -Healthy women with the frequency of soybean-products consumption less than twice a week
-The equol content in urine less than 5.0 micro-mol/g creatinine at isoflavone loading test |
|||
| Key exclusion criteria | -Allergy for soybean and/or milk
-Gly m4 type Oral allergy -Pregnant women -Patients receiving treatment for chronic diseases -Women disqualified by a physician in charge -Subjects who receiving medical treatment by Dysmenorrhea or premenstrual syndrome |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Wayo Women's University | ||||||
| Division name | Human Ecology Department, Graduate School | ||||||
| Zip code | 272-0827 | ||||||
| Address | Kohnodai 2-3-1, Ichikawa, Chiba | ||||||
| TEL | 047-371-2367 | ||||||
| h-nakajima@wayo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Wayo Women's University | ||||||
| Division name | Human Ecology Department, Graduate School | ||||||
| Zip code | 272-0827 | ||||||
| Address | Kohnodai 2-3-1, Ichikawa, Chiba | ||||||
| TEL | 047-371-2367 | ||||||
| Homepage URL | |||||||
| h-nakajima@wayo.ac.jp | |||||||
| Sponsor | |
| Institute | Human Ecology Department, Graduate School of Wayo Women's University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Otsuka Foods Company, Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | JAPAN |
| Other related organizations | |
| Co-sponsor | Biwako Research Institute, Otsuka Foods Company, Ltd. |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics committee of medical and health research involving human subjects, Wayo Women's University |
| Address | Kohnodai 2-3-1, Ichikawa, Chiba, 272-0827 |
| Tel | 047-371-1184 |
| k-shien@wayo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 1847 |
| Org. issuing International ID_1 | Ethics committee of medical and health research involving human subjects, Wayo Women's University |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 和洋女子大学大学院総合生活研究科(Human Ecology Department, Graduate School of Wayo Women’s University) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 38 | ||||||
| Results | |||||||
| Results date posted | |||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041387 |